Hamid Erfanian - 08 Nov 2021 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role: Chief Executive Officer
Signature: /s/ Hamid Erfanian
Issuer symbol: ENZB
Transactions as of: 08 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 10 Nov 2021, 16:20:37 UTC
Next filing: 14 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 Par Value	Award	$0	+260,000		$0.000000	260,000	08 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+700,000		$0.000000	700,000	08 Nov 2021	Common Stock	700,000	$3.39	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.
F2	The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.